Author

Shaoping Ling

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:variant calling· 2 Research Focus:variant effect prediction· 2 Assay:whole-genome sequencing· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Changlin LiuiD· 1 shared Changqing Zeng· 1 shared Cheng LiiD· 1 shared Chung-I Wu· 1 shared Chunyan LiiD· 1 shared Eric A. Hungate· 1 shared Hurng-Yi Wang· 1 shared Jiang Liu· 1 shared

Activity by Year

2015-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Changlin LiuORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GVC: A superfast and universal genomic variant caller

Zhongbo Zhang, Longhui Yin, Lingtong Hao, Lihua Cao, Changlin Liu, Mengzhu Chen, Cheng Li, Zhao Xu, Shaoping Ling

GVC is a fast and universal genomic variant caller that detects SNV, sINDEL, and SV from whole-genome/exome sequencing data with high sensitivity and precision.

bioRxiv · Mar 5, 2019 · PreprintBioinformatics

Further genetic diversification in multiple tumors and an evolutionary perspective on therapeutics

Yong Tao, Zheng Hu, Shaoping Ling, Shiou-Hwie Yeh, Weiwei Zhai, Ke Chen, Chunyan Li, Yu Wang, Kaile Wang, Hurng-Yi Wang, Eric A. Hungate, Kenan Onel, Jiang Liu, Changqing Zeng, Richard R. Hudson, , Chung-I Wu

The study analyzes genetic diversity in multiple hepatocellular carcinomas, finding that low-frequency mutations pre-exist and contribute to drug resistance, presenting challenges and opportunities for cancer therapeutics.

bioRxiv · Aug 25, 2015 · PreprintCancer Biology